BioSpace News Archive

The data published today suggest that AU-011 may be further investigated as a novel first-line treatment option that can enable early intervention and potentially become the standard of care for patients with early-stage ocular melanoma.

The Company has today resolved on issuing altogether 9,910 new shares without payment to two members of the Board of Directors.

argenx increased the Offering from the initially filed offering size of $150 million.

iSee strengthens the iCRO offering by helping biopharmaceutical companies reduce project start-up time and improve user workflows.

MorphoSys will present at the following conferences.

April Roggasch has been promoted to chief financial officer; Brook Pierce to senior director of creative services and internal marketing; Drake Sauer to art director; Carrie Whiting to human resources director; Steph Todd to director of production and sourcing; Kate Covalt to senior program manager; Tess Dugan and Kacia Hughett to program manager and Dallas Bacon to executive assistant to the chief marketing officer.

The new plates are available immediately.

Incyte Corporation announced today that it will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 1:30 pm (PST) in San Francisco.

Beyond the accuracy and reproducibility of the automated and label-free xCELLigence RTCA assay, its streamlined workflow and reduced costs are game changing.

The agreement highlights the two companies’ shared focus on antibiotic stewardship and preventing sepsis in hospital care settings by delivering better solutions for healthcare providers to fight infections and their often-deadly complications.